|
OMIM |
Link |
Information gain |
01 |
|
cerebrohepatorenal syndrome, variant types
|
[NCBI]
|
0.00126888
|
|
|
ST3
|
[NCBI]
|
0.000756859
|
|
|
IDDM
|
[NCBI]
|
0.000435265
|
|
|
XPA
|
[NCBI]
|
0.00035927
|
|
|
FA
|
[NCBI]
|
0.000294928
|
|
|
mucolipidosis ii
|
[NCBI]
|
0.000278622
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
0.000265168
|
|
|
RA
|
[NCBI]
|
0.000223278
|
|
|
ZS
|
[NCBI]
|
0.000209153
|
|
|
UVS
|
[NCBI]
|
0.000199199
|
|
|
sandhoff disease
|
[NCBI]
|
0.000195835
|
|
|
EBVS1
|
[NCBI]
|
0.000171207
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
0.000171207
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
0.000168193
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000141132
|
|
|
FUSE
|
[NCBI]
|
0.000133162
|
|
|
human endogenous retrovirus frd envelope protein
|
[NCBI]
|
0.000125481
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
0.000111557
|
|
|
hyperpipecolatemia
|
[NCBI]
|
0.000105414
|
|
|
ACP5
|
[NCBI]
|
0.000102277
|
|
|
SAI1
|
[NCBI]
|
0.000100753
|
|
|
TSD
|
[NCBI]
|
9.68036e-05
|
|
|
xeroderma pigmentosum ix
|
[NCBI]
|
9.4957e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
8.81752e-05
|
|
|
FANCI
|
[NCBI]
|
8.81752e-05
|
|
|
mucopolysaccharidosis type iiid
|
[NCBI]
|
8.31389e-05
|
|
|
LS
|
[NCBI]
|
8.16484e-05
|
|
|
methylmalonic aciduria, cbla type
|
[NCBI]
|
7.91307e-05
|
|
|
hand-foot-uterus syndrome
|
[NCBI]
|
7.58018e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
7.29558e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
7.04708e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
7.04708e-05
|
|
|
SCZD2
|
[NCBI]
|
6.62851e-05
|
|
|
SLE
|
[NCBI]
|
6.51661e-05
|
|
|
XPF
|
[NCBI]
|
6.44872e-05
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
6.44872e-05
|
|
|
ADAM12
|
[NCBI]
|
6.36216e-05
|
|
|
ERVWE1
|
[NCBI]
|
6.36216e-05
|
|
|
PEX3
|
[NCBI]
|
6.36216e-05
|
|
|
d-bifunctional protein deficiency
|
[NCBI]
|
6.28416e-05
|
|
|
mucolipidosis iiia
|
[NCBI]
|
6.13248e-05
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
6.13248e-05
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
6.13248e-05
|
|
|
IVA
|
[NCBI]
|
5.86077e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
5.73806e-05
|
|
|
FANCE
|
[NCBI]
|
5.6893e-05
|
|
|
GART
|
[NCBI]
|
5.52998e-05
|
|
|
CD9
|
[NCBI]
|
5.52998e-05
|
|
|
PGK1
|
[NCBI]
|
5.4326e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
5.41106e-05
|
|
|
refsum disease, infantile form
|
[NCBI]
|
5.41106e-05
|
|
|
gm1-gangliosidosis, type i
|
[NCBI]
|
5.31343e-05
|
|
|
mucolipidosis iv
|
[NCBI]
|
5.22058e-05
|
|
|
CCR5
|
[NCBI]
|
5.16476e-05
|
|
|
MADD
|
[NCBI]
|
5.13207e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
5.13207e-05
|
|
|
PXMP3
|
[NCBI]
|
4.95297e-05
|
|
|
RCDP1
|
[NCBI]
|
4.81456e-05
|
|
|
CCR2
|
[NCBI]
|
4.63538e-05
|
|
|
gastric cancer
|
[NCBI]
|
4.48119e-05
|
|
|
PKS
|
[NCBI]
|
4.42117e-05
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
4.42117e-05
|
|
|
mitochondrial complex i deficiency
|
[NCBI]
|
4.30669e-05
|
|
|
MTND3
|
[NCBI]
|
4.2284e-05
|
|
|
neuraminidase deficiency
|
[NCBI]
|
4.19896e-05
|
|
|
S8
|
[NCBI]
|
4.17992e-05
|
|
|
NARS
|
[NCBI]
|
4.17992e-05
|
|
|
methylation modifier for class i hla
|
[NCBI]
|
4.17992e-05
|
|
|
BCAR3
|
[NCBI]
|
4.17992e-05
|
|
|
ADAM21
|
[NCBI]
|
4.17992e-05
|
|
|
ADAM20
|
[NCBI]
|
4.17992e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
3.9547e-05
|
|
|
neuroblastoma
|
[NCBI]
|
3.73973e-05
|
|
|
galactosemia
|
[NCBI]
|
3.69969e-05
|
|
|
FANCA
|
[NCBI]
|
3.68876e-05
|
|
|
maple syrup urine disease
|
[NCBI]
|
3.62224e-05
|
|
|
GSR
|
[NCBI]
|
3.46558e-05
|
|
|
NPC1
|
[NCBI]
|
3.4424e-05
|
|
|
BCGF
|
[NCBI]
|
3.40856e-05
|
|
|
SLC7A11
|
[NCBI]
|
3.35568e-05
|
|
|
breast cancer metastasis suppressor 1
|
[NCBI]
|
3.35568e-05
|
|
|
NHCP1
|
[NCBI]
|
3.35568e-05
|
|
|
AT
|
[NCBI]
|
3.34802e-05
|
|
|
CES
|
[NCBI]
|
3.27949e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
3.21844e-05
|
|
|
VEGF
|
[NCBI]
|
3.1113e-05
|
|
|
AVSD
|
[NCBI]
|
3.04748e-05
|
|
|
ATP5J
|
[NCBI]
|
3.04491e-05
|
|
|
STXBP3
|
[NCBI]
|
3.04491e-05
|
|
|
NDUFS6
|
[NCBI]
|
3.04491e-05
|
|
|
ABCB5
|
[NCBI]
|
3.04491e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.94251e-05
|
|
|
PIGB
|
[NCBI]
|
2.84327e-05
|
|
|
IQSEC1
|
[NCBI]
|
2.84327e-05
|
|
|
VAV2
|
[NCBI]
|
2.84327e-05
|
|
|
ST5
|
[NCBI]
|
2.84327e-05
|
|
|
TM7SF4
|
[NCBI]
|
2.84327e-05
|
|
|
BLM
|
[NCBI]
|
2.77352e-05
|
|
|
WRN
|
[NCBI]
|
2.75075e-05
|
|
|
MCAM
|
[NCBI]
|
2.69348e-05
|
|
|
CXCR6
|
[NCBI]
|
2.69348e-05
|
|
|
PCK2
|
[NCBI]
|
2.69348e-05
|
|
|
AK2
|
[NCBI]
|
2.69348e-05
|
|
|
TUBAL1
|
[NCBI]
|
2.57421e-05
|
|
|
PXF
|
[NCBI]
|
2.57421e-05
|
|
|
RFXANK
|
[NCBI]
|
2.57421e-05
|
|
|
PHF9
|
[NCBI]
|
2.57421e-05
|
|
|
MDH2
|
[NCBI]
|
2.47512e-05
|
|
|
ISL1
|
[NCBI]
|
2.39036e-05
|
|
|
BLVRA
|
[NCBI]
|
2.39036e-05
|
|
|
PEX6
|
[NCBI]
|
2.39036e-05
|
|
|
HPRT1
|
[NCBI]
|
2.34485e-05
|
|
|
PGM2
|
[NCBI]
|
2.31633e-05
|
|
|
ERCC4
|
[NCBI]
|
2.31633e-05
|
|
|
MTTE
|
[NCBI]
|
2.31633e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
2.28442e-05
|
|
|
LGALS1
|
[NCBI]
|
2.25061e-05
|
|
|
NANOG
|
[NCBI]
|
2.25061e-05
|
|
|
A4GALT
|
[NCBI]
|
2.25061e-05
|
|
|
CEACAM5
|
[NCBI]
|
2.2394e-05
|
|
|
VAV1
|
[NCBI]
|
2.19155e-05
|
|
|
MDH1
|
[NCBI]
|
2.19155e-05
|
|
|
CCR3
|
[NCBI]
|
2.13792e-05
|
|
|
ERCC8
|
[NCBI]
|
2.13792e-05
|
|
|
AL-A1
|
[NCBI]
|
2.13792e-05
|
|
|
BCAR1
|
[NCBI]
|
2.13792e-05
|
|
|
RFX5
|
[NCBI]
|
2.13792e-05
|
|
|
IDH1
|
[NCBI]
|
2.08881e-05
|
|
|
RASSF1
|
[NCBI]
|
2.04353e-05
|
|
|
XRCC2
|
[NCBI]
|
2.04353e-05
|
|
|
LDLRAP1
|
[NCBI]
|
2.04353e-05
|
|
|
MCP
|
[NCBI]
|
2.02845e-05
|
|
|
FOLR1
|
[NCBI]
|
2.00152e-05
|
|
|
3-@hydroxy-3-methylglutaryl-coa lyase deficiency
|
[NCBI]
|
2.00152e-05
|
|
|
ASNS
|
[NCBI]
|
2.00152e-05
|
|
|
IGLC1
|
[NCBI]
|
1.96236e-05
|
|
|
MTND4L
|
[NCBI]
|
1.96236e-05
|
|
|
NFATC2
|
[NCBI]
|
1.96236e-05
|
|
|
apc gene
|
[NCBI]
|
1.94973e-05
|
|
|
SNAP25
|
[NCBI]
|
1.92568e-05
|
|
|
STX1A
|
[NCBI]
|
1.89119e-05
|
|
|
CMPK1
|
[NCBI]
|
1.89119e-05
|
|
|
ADSL
|
[NCBI]
|
1.85865e-05
|
|
|
SURF1
|
[NCBI]
|
1.85865e-05
|
|
|
CGB
|
[NCBI]
|
1.85865e-05
|
|
|
PCCB
|
[NCBI]
|
1.82785e-05
|
|
|
ENO1
|
[NCBI]
|
1.82785e-05
|
|
|
GALK1
|
[NCBI]
|
1.79862e-05
|
|
|
GHSR
|
[NCBI]
|
1.74428e-05
|
|
|
VAMP2
|
[NCBI]
|
1.71893e-05
|
|
|
PLAT
|
[NCBI]
|
1.71893e-05
|
|
|
TK1
|
[NCBI]
|
1.69466e-05
|
|
|
SLC25A20
|
[NCBI]
|
1.69466e-05
|
|
|
LDHB
|
[NCBI]
|
1.64903e-05
|
|
|
IL4R
|
[NCBI]
|
1.62751e-05
|
|
|
MUT
|
[NCBI]
|
1.60679e-05
|
|
|
TNFRSF6B
|
[NCBI]
|
1.60679e-05
|
|
|
ARSB
|
[NCBI]
|
1.5868e-05
|
|
|
CHGA
|
[NCBI]
|
1.56749e-05
|
|
|
ADK
|
[NCBI]
|
1.56749e-05
|
|
|
IFNB1
|
[NCBI]
|
1.54882e-05
|
|
|
AK1
|
[NCBI]
|
1.53076e-05
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
1.53076e-05
|
|
|
PRKDC
|
[NCBI]
|
1.47981e-05
|
|
|
MTTK
|
[NCBI]
|
1.47981e-05
|
|
|
MTCO2
|
[NCBI]
|
1.46381e-05
|
|
|
IGKC
|
[NCBI]
|
1.46381e-05
|
|
|
CXCR4
|
[NCBI]
|
1.46381e-05
|
|
|
PIGA
|
[NCBI]
|
1.46381e-05
|
|
|
SLAMF1
|
[NCBI]
|
1.46381e-05
|
|
|
CHAT
|
[NCBI]
|
1.45375e-05
|
|
|
SOD1
|
[NCBI]
|
1.45062e-05
|
|
|
INHBA
|
[NCBI]
|
1.44825e-05
|
|
|
MDM2
|
[NCBI]
|
1.44825e-05
|
|
|
TP53
|
[NCBI]
|
1.43567e-05
|
|
|
XPA
|
[NCBI]
|
1.43312e-05
|
|
|
MTCO1
|
[NCBI]
|
1.43312e-05
|
|
|
fucosidosis
|
[NCBI]
|
1.39006e-05
|
|
|
TNF
|
[NCBI]
|
1.35624e-05
|
|
|
GLA
|
[NCBI]
|
1.35012e-05
|
|
|
MTCYB
|
[NCBI]
|
1.35012e-05
|
|
|
PTK2
|
[NCBI]
|
1.32584e-05
|
|
|
ADAM17
|
[NCBI]
|
1.2894e-05
|
|
|
CD47
|
[NCBI]
|
1.2894e-05
|
|
|
IGHG1
|
[NCBI]
|
1.24528e-05
|
|
|
MTND1
|
[NCBI]
|
1.24528e-05
|
|
|
LDLR
|
[NCBI]
|
1.2429e-05
|
|
|
MSH2
|
[NCBI]
|
1.21441e-05
|
|
|
PGM1
|
[NCBI]
|
1.20449e-05
|
|
|
DCC
|
[NCBI]
|
1.19476e-05
|
|
|
SLC2A2
|
[NCBI]
|
1.18521e-05
|
|
|
PRL
|
[NCBI]
|
1.14664e-05
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.11245e-05
|
|
|
GCCR
|
[NCBI]
|
1.10616e-05
|
|
|
CDC2
|
[NCBI]
|
1.10616e-05
|
|
|
MTTL1
|
[NCBI]
|
1.01645e-05
|
|
|
CRC
|
[NCBI]
|
1.01336e-05
|
|
|
IDUA
|
[NCBI]
|
1.00963e-05
|
|
|
BTK
|
[NCBI]
|
9.46056e-06
|
|
|
AFP
|
[NCBI]
|
9.42908e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
9.40118e-06
|
|
|
FGF1
|
[NCBI]
|
9.17043e-06
|
|
|
IL4
|
[NCBI]
|
8.84323e-06
|
|
|
NSF
|
[NCBI]
|
8.73882e-06
|
|
|
GUSB
|
[NCBI]
|
8.58627e-06
|
|
|
PPARG
|
[NCBI]
|
8.02002e-06
|
|
|
NPM1
|
[NCBI]
|
7.88835e-06
|
|
|
IL2
|
[NCBI]
|
7.79764e-06
|
|
|
CJD
|
[NCBI]
|
6.73734e-06
|
|
|
EGF
|
[NCBI]
|
6.71675e-06
|
|
|
KLK3
|
[NCBI]
|
6.67442e-06
|
|
|
FGF2
|
[NCBI]
|
6.61059e-06
|
|
|
G6PD
|
[NCBI]
|
6.49747e-06
|
|
|
TH
|
[NCBI]
|
5.75418e-06
|
|
|
DMD
|
[NCBI]
|
5.22521e-06
|
|
|
ALK
|
[NCBI]
|
5.20175e-06
|
|
|
GFAP
|
[NCBI]
|
4.65762e-06
|
|
|
PLG
|
[NCBI]
|
4.63675e-06
|
|
|
APRT
|
[NCBI]
|
4.29002e-06
|
|
|
ACPP
|
[NCBI]
|
4.18145e-06
|
|
|
CCK
|
[NCBI]
|
4.13601e-06
|
|
|
PTH
|
[NCBI]
|
4.04216e-06
|
|
|
PDCD8
|
[NCBI]
|
3.90734e-06
|
|
|
SPP1
|
[NCBI]
|
3.72575e-06
|
|
|
MAP2
|
[NCBI]
|
3.6843e-06
|
|
|
PI
|
[NCBI]
|
3.60814e-06
|
|
|
GPI
|
[NCBI]
|
3.37583e-06
|
|
|
VIP
|
[NCBI]
|
3.36668e-06
|
|
|
CF
|
[NCBI]
|
2.87228e-06
|
|
|
GJA1
|
[NCBI]
|
2.85012e-06
|
|
|
AR
|
[NCBI]
|
2.80402e-06
|
|
|
ACHE
|
[NCBI]
|
2.77722e-06
|
|
|
MBP
|
[NCBI]
|
1.73128e-06
|
|
|
ALB
|
[NCBI]
|
1.24332e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.07282e-06
|
|
|
EGFR
|
[NCBI]
|
1.06812e-06
|
|
|
HD
|
[NCBI]
|
7.93124e-07
|
|
|
APC
|
[NCBI]
|
6.18677e-07
|
|
|
PTHLH
|
[NCBI]
|
5.66675e-07
|
|
|
NGFB
|
[NCBI]
|
5.61951e-07
|
|
|
PCNA
|
[NCBI]
|
5.58245e-07
|
|
|
CNTF
|
[NCBI]
|
4.19093e-07
|
|
|
TF
|
[NCBI]
|
3.31654e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
3.20519e-07
|
|
|
DHFR
|
[NCBI]
|
1.33764e-07
|
|
|
AHR
|
[NCBI]
|
1.23088e-07
|
|
|
EPO
|
[NCBI]
|
7.07031e-08
|
|
|
ADA
|
[NCBI]
|
4.18699e-08
|
|
|
HGF
|
[NCBI]
|
5.04647e-09
|
|